Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 19990 [2015-08522]

Download as PDF 19990 Federal Register / Vol. 80, No. 71 / Tuesday, April 14, 2015 / Notices Prevention and the Agency for Toxic Substances and Disease Registry. Prevention and the Agency for Toxic Substances and Disease Registry. Claudette Grant, M.P.H., Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Claudette Grant, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2015–08520 Filed 4–13–15; 8:45 am] [FR Doc. 2015–08522 Filed 4–13–15; 8:45 am] BILLING CODE 4163–18–P BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4163–18–P Centers for Disease Control and Prevention Centers for Disease Control and Prevention DEPARTMENT OF HEALTH AND HUMAN SERVICES Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review Disease, Disability, and Injury Prevention and Control Special Emphasis Panel, SEP; Initial Review Centers for Disease Control and Prevention In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to Funding Opportunity Announcements (FOA) PS15–001, Positive Health Check Evaluation, and FOA PS15–002, Mobile Messaging Intervention to Present New HIV Prevention Options for MSM. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to Special Interest Projects (SIP) 15–001, Integrating Self-Management Education with Cancer Survivorship Care Planning, and SIP 15–003, Using Cancer Registry Data to Promote Proactive Tobacco Cessation among Adult Cancer Survivors. TIMES AND DATES: 10:00 a.m.–6:00 p.m., May 12, 2015 (Closed). 10:00 a.m.–6:00 p.m., May 13, 2015 (Closed). PLACE: Teleconference. STATUS: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. MATTERS FOR DISCUSSION: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Integrating Self-Management Education with Cancer Survivorship Care Planning, SIP 15–001, and Using Cancer Registry Data to Promote Proactive Tobacco Cessation among Adult Cancer Survivors, SIP 15–003.’’ CONTACT PERSON FOR MORE INFORMATION: Brenda Colley Gilbert, Ph.D., M.S.P.H., Director, Extramural Research Program Operations and Services, CDC, 4770 Buford Highway NE., Mailstop F–80, Atlanta, Georgia 30341, Telephone: (770) 488–6295, BJC4@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Claudette Grant, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2015–08523 Filed 4–13–15; 8:45 am] TIME AND DATE: 10:00 a.m.–5:00 p.m., May 7, 2015 (Closed). PLACE: Teleconference. The meeting will be closed to the public in accordance with provisions set forth in section 552b(c) (4) and (6), title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. STATUS: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Positive Health Check Evaluation’’, FOA PS15–001, and ‘‘Mobile Messaging Intervention to Present New HIV Prevention Options for MSM’’, FOA PS15–002. MATTERS FOR DISCUSSION: asabaliauskas on DSK5VPTVN1PROD with NOTICES CONTACT PERSON FOR MORE INFORMATION: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE., Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 718– 8833. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and VerDate Sep<11>2014 17:42 Apr 13, 2015 Jkt 235001 PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 Board of Scientific Counselors, National Institute for Occupational Safety and Health, BSC, NIOSH In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting for the aforementioned committee: TIME AND DATE: 8:30 a.m.–2:30 p.m., EDT, May 12, 2015. PLACE: Patriots Plaza I, 395 E Street SW., Room 9000, Washington, DC 20201. STATUS: Open to the public, limited only by the space available. The meeting room accommodates approximately 33 people. If you wish to attend in person or by webcast, please see the NIOSH Web site to register (https:// www.cdc.gov/niosh/bsc/) or call (404) 498–2539 at least five business days in advance of the meeting. Teleconference is available toll-free; please dial (888) 397–9578, Participant Pass Code 63257516. PURPOSE: The Secretary, the Assistant Secretary for Health, and by delegation the Director, Centers for Disease Control and Prevention, are authorized under Sections 301 and 308 of the Public Health Service Act to conduct directly or by grants or contracts, research, experiments, and demonstrations relating to occupational safety and health and to mine health. The Board of Scientific Counselors provides guidance to the Director, National Institute for Occupational Safety and Health on research and prevention programs. Specifically, the Board provides guidance on the Institute’s research activities related to developing and evaluating hypotheses, systematically documenting findings and disseminating results. The Board evaluates the degree to which the activities of the National Institute for Occupational Safety and Health: (1) E:\FR\FM\14APN1.SGM 14APN1

Agencies

[Federal Register Volume 80, Number 71 (Tuesday, April 14, 2015)]
[Notices]
[Page 19990]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-08522]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting for the initial review of 
applications in response to Funding Opportunity Announcements (FOA) 
PS15-001, Positive Health Check Evaluation, and FOA PS15-002, Mobile 
Messaging Intervention to Present New HIV Prevention Options for MSM.

Time and Date: 
10:00 a.m.-5:00 p.m., May 7, 2015 (Closed).

Place: Teleconference.

Status: The meeting will be closed to the public in accordance with 
provisions set forth in section 552b(c) (4) and (6), title 5 U.S.C., 
and the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.

Matters for Discussion: The meeting will include the initial review, 
discussion, and evaluation of applications received in response to 
``Positive Health Check Evaluation'', FOA PS15-001, and ``Mobile 
Messaging Intervention to Present New HIV Prevention Options for MSM'', 
FOA PS15-002.

Contact Person for More Information:  Gregory Anderson, M.S., M.P.H., 
Scientific Review Officer, CDC, 1600 Clifton Road NE., Mailstop E60, 
Atlanta, Georgia 30333, Telephone: (404) 718-8833.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2015-08522 Filed 4-13-15; 8:45 am]
 BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.